Biomarin Pharmaceutical Inc (BMRN)

Days of inventory on hand (DOH)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Inventory turnover		0.47	0.49	0.44	0.46	0.48	0.51	0.52	0.55	0.54	0.57	0.58	0.59	0.61	0.64	0.79	0.75	0.75	0.70	0.54	0.54
DOH	days	775.41	742.72	832.16	799.82	763.05	722.52	698.64	667.91	674.72	643.53	631.98	614.19	602.50	573.56	461.62	488.84	486.33	517.80	675.07	674.85

December 31, 2024 calculation

DOH = 365 ÷ Inventory turnover
= 365 ÷ 0.47
= 775.41

Days of inventory on hand (DOH) for Biomarin Pharmaceutical Inc has shown fluctuations over the years. The trend indicates an increase in DOH from around 675 days in mid-2020 to a peak of over 800 days by mid-2024, with occasional fluctuations in between.

A high number of days of inventory on hand may suggest that the company is struggling to sell its products efficiently, leading to excess inventory levels. This could tie up capital and increase holding costs, negatively impacting the company's cash flow and profitability.

On the other hand, a low DOH may indicate efficient inventory management, with quick turnover of stock. However, an extremely low DOH could also mean stockouts and potential lost sales if demand exceeds supply.

It would be important for Biomarin Pharmaceutical Inc to regularly assess and optimize its inventory management practices to strike a balance between maintaining adequate stock levels and avoiding overstock situations. This could involve streamlining production processes, improving demand forecasting accuracy, and implementing inventory control measures to ensure the optimal level of inventory on hand.